
Obesity is recognized as a complex metabolic disease affecting over a billion people globally, linked to numerous health issues. While lifestyle changes like balanced nutrition and exercise remain fundamental, GLP-1 analogues such as semaglutide and tirzepatide offer medical support by regulating appetite and improving metabolic health, with emerging drugs showing promising results. Some foods naturally stimulate similar satiety hormones, aiding fullness and gastric slowing. Experts emphasize combining pharmacological treatments with muscle building and holistic approaches to address obesity effectively.
Select a news story to see related coverage from other media outlets.